SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Dyne Therapeutics announced full enrollment in the registrational expansion cohort of its ACHIEVE trial for Z-basivarsen, with topline data expected in Q1 2027 to support potential…
TG Therapeutics announced positive pharmacokinetic and pharmacodynamic results from a Phase 1 trial of subcutaneous BRIUMVI, demonstrating greater than 60% bioavailability and supp…
Cabaletta announced encouraging Phase 1/2 clinical data for rese-cel across dermatomyositis, systemic sclerosis, and lupus, with 83% of dermatomyositis patients meeting registratio…
FortuneX Acquisition Corporation's May 26, 2026 balance sheet audit raised substantial doubt about the company's ability to continue as a going concern, contingent on completing a …
Sadot Group Inc. submitted an exhibit containing corporate bylaws or charter information in an 8-K filing. The filing appears to be a routine governance document submission with un…
Orgenesis Inc. submitted an amended certificate of incorporation to the SEC as part of routine corporate governance documentation. The filing reflects standard organizational updat…
BDO USA, P.C. confirmed agreement with statements made by Redwood Mortgage Investors VIII regarding an auditor change on May 29, 2026. The filing represents a routine accounting fi…
Toppoint Holdings issued a statement pursuant to NYSE American rules confirming it is unaware of any material corporate developments explaining unusual trading activity in its comm…
Booking Holdings amended its restated certificate of incorporation to extend director and officer liability protections to officers under Delaware law. The change broadens exculpat…
Atlantic American Corporation executed a second amendment to its revolving credit agreement with Truist Bank, effective May 27, 2026, modifying financial reporting requirements. Th…
Ausenco Engineering USA South Inc. consented to the filing of a technical report summary for Hycroft Mining's Nevada operations with an effective date of May 14, 2026. The consent …
CNL Strategic Capital, LLC amended its loan agreement with Valley National Bank to extend the revolving maturity date and increase the maximum commitment to $50M with an additional…
ADC Therapeutics SA updated its Articles of Association, establishing corporate governance structure with registered office in Epalinges, Switzerland. The filing documents standard…
INmune Bio reported Phase 2 MINDFuL trial results showing XPro1595 demonstrated significant treatment effects on advanced white matter MRI biomarkers (p=0.0028), with stronger effi…
Federal Reserve agencies have eliminated further references to reputation risk from regulatory guidance or policy documents. The action reflects a shift in how regulators address r…
Canadian Derivatives Clearing Corporation filed an 8-K on June 2, 2026 disclosing an updated list of underlying interests for options traded on the Montreal Exchange and offered in…
The FDA released draft guidance to help developers bring gene therapies to market more efficiently by leveraging existing scientific and regulatory knowledge. The measure aims to s…
Intelligent Bio Solutions initiated a clinical study with CenExel to validate its Intelligent Fingerprinting Drug Screening System for FDA clearance, with enrollment completion exp…
Triller Group received an exception from the Nasdaq Hearings Panel on May 29, 2026 to regain compliance with the Bid Price Rule by June 30, 2026. This marks the company's third suc…
Cingulate received an FDA Complete Response Letter for its ADHD drug CTx-1301 with only Chemistry, Manufacturing and Controls (CMC) information requests and no clinical safety or e…